Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: A randomized controlled trial

Journal of Pediatrics

Volumn 143, Issue 1, 2003, Pages 111-114

  Kalra, Veena ^a   Dua, Tarun ^a   Kumar, Virender ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; DEXAMETHASONE; PHENYTOIN; PRAZIQUANTEL;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTICERCUS; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROCYSTICERCOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK; SEIZURE; SHORT COURSE THERAPY; VISUAL DISORDER; VOMITING;

EID: 0042243541     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(03)00211-7     Document Type: Article

References (26)

1. Wadia RS, Makhale CN, Kelkar AV, Grant KB. Focal epilepsy in India with special reference to lesions showing ring or disc like enhancement on contrast computed tomography. J Neurol Neurosurg Psychiatry 1987;50:1298-301.
2. Medina M, Rosas E, Rubio-Donnadieu F, Sotelo J. Neurocysticercosis as the main cause of late onset epilepsy in Mexico. Arch Intern Med 1990;150:325-7.
3. Kalra V, Bagga A, Sethi A. Etiology of partial seizures in children: a clinico-CT study. In: Ohtabana S, Roger J, eds. New trends in pediatric epileptology. 1991. p. 129-35.
4. Chopra JS, Sawhney IMS, Suresh N, Pravhakar S, Dhand UK, Suri S. Vanishing CT lesions in epilepsy. J Neurol Sci 1992;107:40-9.
5. Garcia HH, Gilman R, Martinez M, Tsang VC, Pilcher JB, Herrera G, et al. Cysticercosis as a major cause of epilepsy in Peru. Lancet 1993;341:197-200.
6. Garg RK, Nag D. Single ring or disc enhancing computed tomographic lesion in Indian children and adolescents after first seizure [letter]. Arch Pediatr Adolesc Med 1997;157:632-4.
7. Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia 1998;39:1025-40.
8. Singhi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Child Neurol 2000;15:207-13.
9. Tandon PN, Bhargava S. CNS tuberculosis: lessons learnt from CT studies. Neurol India 1980;28:225-30.
10. Rajshekhar V, Haran RP, Prakash GS, Chandy MJ. Differentiating solitary small cysticercus granluomas and tuberculomas in patients with epilepsy: clinical and computerised tomographic criteria. J Neurosurg 1993;78:402-7.
11. Rajshekhar V, Chacko G, Haran RP, Chandy MJ, Chandi SM. Clinicoradiological and pathological correlation in patients with solitary cysticercus granuloma and epilepsy focus on presence of the parasite and edema formation. J Neurol Neurosurg Psychiatry 1995;59:284-6.
12. Salinas R, Prasad K. Drugs for treating neurocysticercosis (tapeworm infection of the brain) (Cochrane Review). In: The Cochrane Library, Issue 2, 20014th ed.. Oxford: Update Software.
13. Carpio A, Santillan F, Leon P, Flores C, Hauser WA. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 1995;155:1982-8.
14. Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in neurocysticercosis. Natl Med J India 1995;8:25-8.
15. Garg RK. Drug treatment of neurocysticercosis. Natl Med J India 1997;10:173-7.
16. Miller B, Grinnell V, Goldberg M, Heiner D. Spontaneous radiographic disappearance of cerebral cysticercosis: three cases. Neurology 1983;33:1377-9.
17. Garg RK, Singh MK, Misra S. Single-enhancing CT lesions in Indian patients with seizures: a review. Epilepsy Res 2000;38:91-104.
18. Takayanagui OM, Jardim E. Therapy for neurocysticercosis: comparison between albendazole and praziquantel. Arch Neurol 1992;49:290-4.
19. Del Brutto OH. Prognostic factors for seizure recurrence after withdrawal of anti-epileptic drugs in patients with neurocysticercosis. Neurology 1994;44:1706-9.
20. Del Brutto OH. Neurocysticercosis in children, clinical and radiological analysis and prognostic factors in 54 patients. Rev Neurol 1997;25:1681-4.
21. Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327:696-701.
22. Medina MT, Genton P, Montoya MC, Cordova S, Dravet C, Sotelo J. Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial. Epilepsia 1993;34:1024-7.
23. Santos IC, Kobayashi E, Cardoso TM, Guerreiro CA, Cendes F. Cysticidal therapy: impact on seizure control in epilepsy associated with neurocysticercosis. Arq Neuropsiquiatr 2000;58:1014-20.
24. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizures and single small enhancing computerised tomographic lesions: a randomised, placebo-controlled, double blind trial. Pediatr Infect Dis J 1998;17:696-700.
25. Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in single CT ring lesions in epilepsy. Neurology 1994;44:1344-6.
26. Salinas R, Counsell C, Prasad K, Celband H, Garner P. Treating neurocysticercosis medically: a systematic review of randomized controlled trials. Trop Med Int Health 1999;4:713-8.